• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用半自动反相高效液相色谱法测定小鼠血浆、组织、尿液和粪便中的紫杉醇及其代谢物。

Determination of paclitaxel and metabolites in mouse plasma, tissues, urine and faeces by semi-automated reversed-phase high-performance liquid chromatography.

作者信息

Sparreboom A, van Tellingen O, Nooijen W J, Beijnen J H

机构信息

Department of Pharmacy, Slotervaart Hospital, Amsterdam, Netherlands.

出版信息

J Chromatogr B Biomed Appl. 1995 Feb 17;664(2):383-91. doi: 10.1016/0378-4347(94)00495-q.

DOI:10.1016/0378-4347(94)00495-q
PMID:7780591
Abstract

We have developed and validated a sensitive and selective assay for the quantification of paclitaxel and its metabolites 6 alpha, 3'-p-dihydroxypaclitaxel, 3'-p-hydroxypaclitaxel and 6 alpha-hydroxypaclitaxel in plasma, tissue, urine and faeces specimens of mice. Tissue and faeces were homogenized (approximately 0.1-0.2 g/ml) in bovine serum albumin (40 g/l) in water, and urine was diluted (1:5, v/v) in blank human plasma. Sample pretreatment involved liquid-liquid extraction of 200-1000 microliters of sample with diethyl ether followed by automated solid-phase extraction using cyano Bond Elut columns. 2'-Methylpaclitaxel was used as internal standard. The overall recovery of the sample pretreatment procedure ranged from 76 to 85%. In plasma, the lower limit of detection (LOD) and the lower limit of quantitation (LLQ) are 15 and 25 ng/ml, respectively, using 200 microliters of sample. In tissues, faeces and urine the LLQs are 25-100 ng/g, 125 ng/g and 25 ng/ml, respectively, using 1000 microliters (faeces: 200 microliters) of homogenized or diluted sample. The concentrations in the various biological matrices, for validation procedures spiked with known amounts of the test compounds, are read from calibration curves constructed in blank human plasma in the range 25-100,000 ng/ml for paclitaxel and 25-500 ng/ml for the metabolites. The accuracy and precision of the assay fall within the generally accepted criteria for bio-analytical assays.

摘要

我们已经开发并验证了一种灵敏且具选择性的分析方法,用于定量小鼠血浆、组织、尿液和粪便样本中的紫杉醇及其代谢物6α,3'-对羟基紫杉醇、3'-对羟基紫杉醇和6α-羟基紫杉醇。将组织和粪便在水中的牛血清白蛋白(40 g/l)中匀浆(约0.1 - 0.2 g/ml),尿液在空白人血浆中按1:5(v/v)稀释。样品预处理包括用乙醚对200 - 1000微升样品进行液 - 液萃取,随后使用氰基Bond Elut柱进行自动固相萃取。2'-甲基紫杉醇用作内标。样品预处理程序的总回收率在76%至85%之间。在血浆中,使用200微升样品时,检测下限(LOD)和定量下限(LLQ)分别为15和25 ng/ml。在组织、粪便和尿液中,使用1000微升(粪便:200微升)匀浆或稀释样品时,LLQ分别为25 - 100 ng/g、125 ng/g和25 ng/ml。对于用已知量的测试化合物加标的验证程序,各种生物基质中的浓度从空白人血浆中构建的校准曲线读取,紫杉醇的范围为25 - 100,000 ng/ml,代谢物的范围为25 - 500 ng/ml。该分析方法的准确度和精密度符合生物分析方法普遍接受的标准。

相似文献

1
Determination of paclitaxel and metabolites in mouse plasma, tissues, urine and faeces by semi-automated reversed-phase high-performance liquid chromatography.采用半自动反相高效液相色谱法测定小鼠血浆、组织、尿液和粪便中的紫杉醇及其代谢物。
J Chromatogr B Biomed Appl. 1995 Feb 17;664(2):383-91. doi: 10.1016/0378-4347(94)00495-q.
2
Quantification of paclitaxel metabolites in human plasma by high-performance liquid chromatography.高效液相色谱法测定人血浆中紫杉醇代谢物
J Chromatogr B Biomed Appl. 1995 Dec 15;674(2):261-8. doi: 10.1016/0378-4347(95)00308-8.
3
High-performance liquid chromatographic procedures for the quantitative determination of paclitaxel (Taxol) in human urine.
J Chromatogr B Biomed Appl. 1995 Feb 17;664(2):373-82. doi: 10.1016/0378-4347(94)00477-m.
4
Bio-analysis of docetaxel and hydroxylated metabolites in human plasma by high-performance liquid chromatography and automated solid-phase extraction.
J Chromatogr B Biomed Sci Appl. 1997 Aug 15;696(1):89-98. doi: 10.1016/s0378-4347(97)00209-0.
5
Determination of a new polymer-bound paclitaxel derivative (PNU 166945), free paclitaxel and 7-epipaclitaxel in dog plasma and urine by reversed-phase high-performance liquid chromatography with UV detection.采用反相高效液相色谱-紫外检测法测定犬血浆和尿液中一种新型聚合物结合紫杉醇衍生物(PNU 166945)、游离紫杉醇和7-表紫杉醇。
J Chromatogr A. 1998 Feb 27;797(1-2):295-303. doi: 10.1016/s0021-9673(97)01204-1.
6
Sensitive determination of docetaxel in human plasma by liquid-liquid extraction and reversed-phase high-performance liquid chromatography.通过液液萃取和反相高效液相色谱法灵敏测定人血浆中的多西他赛。
J Chromatogr B Biomed Sci Appl. 1997 Jun 6;693(2):437-41. doi: 10.1016/s0378-4347(97)00089-3.
7
Determination of paclitaxel in human plasma using single solvent extraction prior to isocratic reversed-phase high-performance liquid chromatography with ultraviolet detection.在等度反相高效液相色谱-紫外检测之前,采用单溶剂萃取法测定人血浆中的紫杉醇。
J Chromatogr B Biomed Sci Appl. 1998 Jan 23;705(1):159-64. doi: 10.1016/s0378-4347(97)00502-1.
8
Assay of paclitaxel (Taxol) in plasma and urine by high-performance liquid chromatography.采用高效液相色谱法测定血浆和尿液中的紫杉醇(泰素)。
J Chromatogr B Biomed Sci Appl. 1998 May 29;709(2):281-8. doi: 10.1016/s0378-4347(98)00060-7.
9
Combined quantification of paclitaxel, docetaxel and ritonavir in human feces and urine using LC-MS/MS.使用液相色谱-串联质谱法对人粪便和尿液中的紫杉醇、多西他赛和利托那韦进行联合定量分析。
Biomed Chromatogr. 2014 Feb;28(2):302-10. doi: 10.1002/bmc.3021. Epub 2013 Aug 29.
10
Simple and sensitive high-performance liquid chromatography method for the determination of docetaxel in human plasma or urine.用于测定人血浆或尿液中多西他赛的简单灵敏的高效液相色谱法。
J Chromatogr B Biomed Sci Appl. 2000 Oct 10;748(2):383-8. doi: 10.1016/s0378-4347(00)00356-x.

引用本文的文献

1
Carotid artery infusions for pharmacokinetic and pharmacodynamic analysis of taxanes in mice.用于小鼠紫杉烷药代动力学和药效学分析的颈动脉输注
J Vis Exp. 2014 Oct 27(92):e51917. doi: 10.3791/51917.
2
"Effect of the drug transporters ABCB1, ABCC2, and ABCG2 on the disposition and brain accumulation of the taxane analog BMS-275,183".药物转运体ABCB1、ABCC2和ABCG2对紫杉烷类似物BMS-275,183的处置及脑内蓄积的影响
Invest New Drugs. 2014 Dec;32(6):1083-95. doi: 10.1007/s10637-014-0143-0. Epub 2014 Jul 31.
3
Nanosuspension delivery of paclitaxel to xenograft mice can alter drug disposition and anti-tumor activity.
纳米悬浮液递送紫杉醇给异种移植小鼠可改变药物处置和抗肿瘤活性。
Nanoscale Res Lett. 2014 Apr 1;9(1):156. doi: 10.1186/1556-276X-9-156.
4
Biodistribution and pharmacokinetics of a telodendrimer micellar paclitaxel nanoformulation in a mouse xenograft model of ovarian cancer.紫杉醇树枝状大分子胶束纳米制剂在卵巢癌小鼠异种移植模型中的生物分布和药代动力学。
Int J Nanomedicine. 2012;7:1587-97. doi: 10.2147/IJN.S29306. Epub 2012 Mar 27.
5
Formulation and pharmacokinetic evaluation of a paclitaxel nanosuspension for intravenous delivery.紫杉醇纳米混悬剂的制备及静脉给药的药代动力学评价。
Int J Nanomedicine. 2011;6:1497-507. doi: 10.2147/IJN.S21097. Epub 2011 Jul 13.
6
Paclitaxel in self-micro emulsifying formulations: oral bioavailability study in mice.紫杉醇自微乳化制剂:小鼠口服生物利用度研究
Invest New Drugs. 2010 Apr 13;29(5):768-76. doi: 10.1007/s10637-010-9421-7. Print 2011 Oct.
7
A unique carrier for delivery of therapeutic compounds beyond the blood-brain barrier.一种用于将治疗性化合物递送至血脑屏障之外的独特载体。
PLoS One. 2008 Jun 25;3(6):e2469. doi: 10.1371/journal.pone.0002469.
8
Effect of the ABCB1 modulators elacridar and tariquidar on the distribution of paclitaxel in nude mice.ABCB1调节剂艾拉司群和他林喹达对紫杉醇在裸鼠体内分布的影响。
J Cancer Res Clin Oncol. 2008 May;134(5):597-607. doi: 10.1007/s00432-007-0323-9. Epub 2007 Oct 12.
9
Efficacy of novel P-glycoprotein inhibitors to increase the oral uptake of paclitaxel in mice.新型P-糖蛋白抑制剂提高小鼠口服紫杉醇摄取量的疗效。
Invest New Drugs. 2004 Aug;22(3):219-29. doi: 10.1023/B:DRUG.0000026248.45084.21.
10
Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo.紫杉醇(泰素)在体外和体内通过血脑屏障的转运。
J Clin Invest. 2002 Nov;110(9):1309-18. doi: 10.1172/JCI15451.